Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone

Biochemical Pharmacology

Volumn 59, Issue 11, 2000, Pages 1365-1373

  Ferrali, Marco ^a   Signorini, Cinzia ^a   Ciccoli, Lucia ^a   Bambagioni, Sabrina ^a   Rossi, Viviana ^a   Pompella, Alfonso ^a   Comporti, Mario ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Erythrocytes; Fluor benzoil pyridoxal hydrazone; Iron chelation; Iron release; Oxidative stress; Senescent cell antigen

Indexed keywords

FLUOR BENZOIL PYRIDOXAL HYDRAZONE; IMMUNOGLOBULIN G; IRON CHELATING AGENT; PHENYLHYDRAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; HEMOLYSIS; IRON CHELATION; IRON TRANSPORT; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, DIFFERENTIATION; ERYTHROCYTES; HYDRAZONES; IMMUNOGLOBULIN G; IRON; IRON CHELATING AGENTS; MICE; OXIDATIVE STRESS; PROTECTIVE AGENTS; PYRIDOXAL;

EID: 0034213869     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00273-2     Document Type: Article

References (38)

1. DiGuiseppi J., Fridovich I. The toxicology of molecular oxygen. Crit Rev Toxicol. 12:1987;315-342.
2. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 219:1985;1-14.
3. Halliwell B., Gutteridge J.M. The importance of free radicals and catalytic metal ions in human disease. Mol Aspects Med. 8:1985;89-193.
4. Ryan T.P., Aust S.D. The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol. 22:1992;119-141.
5. Crichton R.R., Charloteaux-Wauters M. Iron transport and storage. Eur J Biochem. 164:1987;485-506.
6. Ferrali M., Ciccoli L., Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem Pharmacol. 38:1989;1819-1825.
7. Ferrali M., Signorini C., Ciccoli L., Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J. 285:1992;295-301.
8. Ciccoli L., Ferrali M., Rossi V., Signorini C., Alessandrini C., Comporti M. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol Lett. 110:1999;57-66.
9. Ferrali M., Ciccoli L., Signorini C., Comporti M. Iron release and erythrocyte damage in allyl alcohol intoxication mice. Biochem Pharmacol. 40:1990;1484-1490.
10. Ciccoli L., Signorini C., Alessandrini C., Ferrali M., Comporti M. Iron release, lipid peroxidation, and morphological alterations of erythrocytes exposed to acrolein and phenylhydrazine. Exp Mol Pathol. 60:1994;108-118.
11. Rice-Evans C., Baysal E., Singh S., Jones S.A., Jones J.G. The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes. FEBS Lett. 256:1989;17-20.
12. Lloyd J.B., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem Pharmacol. 41:1991;1361-1363.
13. Ferrali M., Signorini C., Caciotti B., Sugherini L., Ciccoli L., Giachetti D., Comporti M. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416:1997;123-129.
14. Kay M.M. Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci USA. 72:1975;3521-3525.
15. Kay M.M. Isolation of the phagocytosis-inducing IgG-binding antigen on senescent somatic cells. Nature. 289:1981;491-494.
16. Signorini C., Ferrali M., Ciccoli L., Sugherini L., Magnani A., Comporti M. Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett. 362:1995;165-170.
17. Caria H., Chaveca T., Laires A., Rueff J. Genotoxicity of quercetin in the micronucleus assay in mouse bone marrow erythrocytes, human lymphocytes, V79 cell line and identification of kinetochore-containing (CREST staining) micronuclei in human lymphocytes. Mutat Res. 343:1995;85-94.
18. Uddin S. Repair of quercetin-induced single-strand breaks by a cell free system. Biochem Mol Biol Int. 32:1994;341-347.
19. Laughton M.J., Halliwell B., Evans P.J., Hoult J.R. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem Pharmacol. 38:1989;2859-2865.
20. Avramovici-Grisaru S., Sarel S., Link G., Hershko C. Syntheses of iron bis(pyridoxal isonicotinoyl hydrazone) and the in vivo iron-removal properties of some pyridoxal derivatives. J Med Chem. 26:1983;298-302.
21. Baker E., Vitolo M.L., Webb J. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture. Biochem Pharmacol. 34:1985;3011-3017.
22. Edward J.T., Gauthier M., Chubb F.L., Ponka P. Synthesis of new acylhydrazones as iron-chelating compounds. J Chem Eng Data. 33:1988;538-540.
23. Johnson D.K., Pippard M.J., Murphy T.B., Rose N.J. An in vivo evaluation of iron-chelating drugs derived from pyridoxal and its analogues. J Pharmacol Exp Ther. 221:1982;399-403.
24. Ponka P., Richardson D., Baker E., Schulman H.M., Edward J.T. Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes. Biochim Biophys Acta. 967:1988;122-129.
25. Rama R., Octave J.N., Schneider Y.J., Sibille J.C., Limet J.N., Mareschal J.C., Trouet A., Crichton R.R. Iron mobilization from cultured rat fibroblasts and hepatocytes. FEBS Lett. 127:1981;204-206.
26. Ponka P., Grady R.W., Wilczynska A., Schulman H.M. The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone. Biochim Biophys Acta. 802:1984;477-489.
27. Ponka P., Borova J., Neuwirt J., Fuchs O., Necas E. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents. Biochim Biophys Acta. 586:1979;278-297.
28. Brittenham G.M. Pyridoxal isonicotinoyl hydrazone An effective iron-chelator after oral administration . Semin Hematol. 27:1990;112-116.
29. Sah P.P. Hydrazides as characteristic derivatives for the identification of esters, acids, salts, acid halides, acid anhydrides, acid amides, ureas and nitriles. Recl Trav Chim. 50:1990;1036-1054.
30. Edward J.T., Gauthier M., Chubb F.L., Ponka P. Synthesis of new acylhydrazones as iron-chelating compounds. J Chem Eng Data. 33:1988;538-540.
31. Drabkin D.L., Austin J.H. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 98:1932;719-723.
32. Evelyn K.A., Malloy H.T. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem. 126:1938;655-662.
33. Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J Lab Clin Med. 61:1963;882-888.
34. Comporti M., Hartman A., Di Luzio N.R. Effects of in vivo and in vitro ethanol administration on liver lipid peroxidation. Lab Invest. 16:1967;616-624.
35. Good A.H., Wofsy L., Kimura J., Henry C. Purification of immunoglobulins and their fragments. Mishell B.B., Shiigi S.M. Selected Methods in Cellular Immunology. 1986;278-281 WH Freeman, New York.
36. Levy H.B., Sober H.A. A simple chromatographic method for preparation of gamma globulin. Proc Soc Exp Biol Med. 103:1960;250-252.
37. Miki M., Tamai H., Mino M., Yamamoto Y., Niki E. Free-radical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by α-tocopherol. Arch Biochem Biophys. 258:1987;373-380.
38. Hershko C. Control of disease by selective iron depletion A novel therapeutic strategy utilizing iron chelators . Baillières Clin Haematol. 7:1994;965-1000.